SPY326.54-3.44 -1.04%
DIA265.06-1.53 -0.57%
IXIC10,911.59-274.00 -2.45%

Nurix Therapeutics Q3 EPS $(0.59) Misses $(0.41) Estimate, Sales $4.08M Miss $6.34M Estimate

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.41) by 43.9 percent. This is a 10.61 percent increase over losses of $(0.66) per share

· 10/14/2020 16:07
Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.41) by 43.9 percent. This is a 10.61 percent increase over losses of $(0.66) per share from the same period last year. The company reported quarterly sales of $4.08 million which missed the analyst consensus estimate of $6.34 million by 35.57 percent. This is a 61.39 percent decrease over sales of $10.58 million the same period last year.